Aram Loeb, MD
Urology · Detroit, MINPI 1598015125
Payments from drug & device makers
Across 635 payments — averaging $176.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$97K
- Boston Scientific$7K
- Endo Pharmaceuticals Inc.$3K
- Axonics, Inc.$2K
- Antares Pharma, Inc.$393
- Zyla Life Sciences, Inc.$305
- plus $2K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 291 | $97,359 |
| Boston Scientific | 155 | $7,431 |
| Endo Pharmaceuticals Inc. | 8 | $3,218 |
| Axonics, Inc. | 39 | $1,826 |
| Antares Pharma, Inc. | 29 | $393 |
| Zyla Life Sciences, Inc. | 60 | $305 |
| Neotract Inc. | 6 | $211 |
| Stryker | 2 | $188 |
| Procept Biorobotics Corporation | 2 | $158 |
| Astellas Pharma US Inc | 7 | $127 |
| Endo USA, Inc. | 1 | $112 |
| Tolmar, Inc. | 4 | $91 |
| Rochester Medical Corporation | 2 | $75 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $73 |
| AbbVie(2 entities) | 3 | $73 |
| Teleflex LLC | 3 | $68 |
| Convatec Inc. | 2 | $47 |
| Olympus America Inc. | 3 | $43 |
| Clarus Therapeutics Inc. | 3 | $39 |
| Halozyme Inc | 2 | $37 |
| Rigicon,inc. | 2 | $33 |
| Dentsply IH AB | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Sagent Pharmaceuticals | 1 | $18 |
| Photocure Inc | 1 | $16 |
| Dentsply IH Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Richard Wolf Medical Instruments Corp. | 1 | $14 |
| Ambu Inc. | 1 | $5 |
How this compares
$112,054 in reported general payments places this provider in the 90th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Detroit
- James PeabodyDetroit$2.1M
- Michael CherDetroit$132K
- Craig RogersDetroit$120K
- David LeavittDetroit$59K
- Samantha RaffeeDetroit$28K
- Firas AbdollahDetroit$25K
- Naveen KachrooDetroit$25K
- Amit PatelDetroit$22K
- Asha JamzadehDetroit$21K
- Jason HafronWest Bloomfield$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.